Maravai Lifesciences Holdings (MRVI) Assets (2020 - 2025)
Maravai Lifesciences Holdings has reported Assets over the past 6 years, most recently at $770.6 million for Q4 2025.
- Quarterly results put Assets at $770.6 million for Q4 2025, down 23.57% from a year ago — trailing twelve months through Dec 2025 was $770.6 million (down 23.57% YoY), and the annual figure for FY2025 was $770.6 million, down 23.57%.
- Assets for Q4 2025 was $770.6 million at Maravai Lifesciences Holdings, down from $849.2 million in the prior quarter.
- Over the last five years, Assets for MRVI hit a ceiling of $2.3 billion in Q1 2023 and a floor of $770.6 million in Q4 2025.
- Median Assets over the past 5 years was $1.5 billion (2021), compared with a mean of $1.6 billion.
- Biggest five-year swings in Assets: skyrocketed 51.15% in 2022 and later crashed 43.63% in 2024.
- Maravai Lifesciences Holdings' Assets stood at $1.9 billion in 2021, then increased by 18.98% to $2.3 billion in 2022, then plummeted by 34.83% to $1.5 billion in 2023, then crashed by 32.22% to $1.0 billion in 2024, then decreased by 23.57% to $770.6 million in 2025.
- The last three reported values for Assets were $770.6 million (Q4 2025), $849.2 million (Q3 2025), and $897.0 million (Q2 2025) per Business Quant data.